Evidence map›Paper›PMID 41894311›Full record

ArticleMedicine2026

Enhancing Korean adolescent suicide risk prediction with TabR: A generative AI and explainable retrieval-based deep learning approach.

Haewon Byeon

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Haewon ByeonDepartment of Future Technology, Worker's Care & Digital Health Lab, Korea University of Technology and Education, Cheonan, South Korea.ORCID 0000-0002-3363-390

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adolescent suicide is a growing public health crisis, particularly in South Korea, which has one of the highest youth suicide rates among Organization for Economic and Development countries. Suicide is the leading cause of death among South Koreans aged 10 to 39 years, driven by academic stress, mental health conditions, and social pressures. The early identification of at risk individuals is crucial for timely intervention. This study presents a novel application of TabR, a retrieval-augmented residual neural architecture, for predicting suicide attempts among adolescents, using the Korea Youth Risk Behavior Survey dataset from 2020 to 2022, comprising 1,61,646 participants. To address the extreme class imbalance and limited positive cases, we employed a tabular variational autoencoder for synthetic data augmentation, improving minority class representation while preserving feature distribution fidelity. TabR was compared against 8 baseline machines learning and deep learning models: AdaBoost, CatBoost, LightGBM, XGBoost, Random Forest, SAINT, TabNet, and FT-Transformer. TabR trained on TVAE-augmented data achieved the highest accuracy of 0.9726, AUC of 0.8963, and F1-score of 0.4754. While our findings demonstrate notable improvements in performance, limitations remain, particularly regarding the dataset size, class imbalance, and lack of external validation. Future research should prioritize external validation in independent cohorts, prospective or longitudinal study designs, and explicit evaluation of clinical impact and potential harms (including consequences of false positives and false negatives) before any consideration of deployment.

Indexed as

Deep LearningSuicideSuicide, AttemptedAdolescentFemaleGenerative Artificial IntelligenceHumansMalePrediction AlgorithmsPredictive Learning ModelsRepublic of KoreaRisk Assessmentadolescent suicidal predictionexplainable AITabRtransformervariational autoencoder

Identifiers

PMID41894311
PMCPMC13034906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.